Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Eve & Co Receives Oil Extraction License From Health Canada
SOURCE: https://mjobserver.com/investments/eve-co-receives-oil-extraction-license-from-health-canada/
Toronto, ON — September 17, 2018 — /D.M.O. Newswire/ — Eve & Co Incorporated (the “Company” or “Eve”) (TSXV:EVE) is pleased to announce that its wholly-owned subsidiary, Natural MedCo Ltd., has received an amended license from Health Canada under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) for the production of bottled cannabis oil.
“We are pleased to announce that we have been granted a license to produce extracts,” said CEO, Melinda Rombouts. “We are currently expanding our greenhouse from 220,000 sq. ft to 1,000,000 sq. ft. to meet the expected demand from the consumer market. As one of Canada’s largest producers of dried flower, we believe we can become a leading supplier in the extracts market as well. This license furthers our ability to produce and market a wide array of products focused on addressing women’s needs under our recreational brand Eve.”
FULL RELEASE: https://mjobserver.com/investments/eve-co-receives-oil-extraction-license-from-health-canada/
CannaRoyalty to Sell Equity Stake in Wagner Dimas to Australis Cannabis
SOURCE: https://mjobserver.com/investments/cannaroyalty-to-sell-equity-stake-in-wagner-dimas-to-australis-cannabis/
Ottawa, ON — September 17, 2018 — /D.M.O. Newswire/ — CannaRoyalty Corp. (CSE:CRZ) (OTC:CNNRF) (“CannaRoyalty” or the “Company”), a leading North American cannabis products and brands company, announced today that it has signed a letter of intent (the “Agreement”) with Australis Capital Inc. (“Australis”) whereby Australis intends to purchase 2,200,000 shares of common stock (the “Share Purchase”) in the capital of Wagner Dimas Inc. (“Wagner Dimas”) from Cannroy Delaware Inc. (“Cannroy Delaware”), a wholly-owned subsidiary of CannaRoyalty Corp. This announcement follows the announcement of the sale of the Company’s exclusive Canadian license for Wagner Dimas’ pre-roll technology to Aurora Cannabis.
Pursuant to the Agreement, Australis intends to purchase Cannroy Delaware’s 22% equity interest in Wagner Dimas. As consideration for the Share Purchase, Australis would pay C$3,000,000, payable in either common shares of Australis or cash.
FULL RELEASE: https://mjobserver.com/investments/cannaroyalty-to-sell-equity-stake-in-wagner-dimas-to-australis-cannabis/
Invictus Hires Ex-Heineken Executive Kevin Smith as VP Recreational Sales; Sarah Hardy as VP Medical Sales
SOURCE: https://mjobserver.com/investments/invictus-hires-ex-heineken-executive-kevin-smith-as-vp-recreational-sales-sarah-hardy-as-vp-medical-sales/
Vancouver, BC — September 17, 2018 — /D.M.O. Newswire/ — INVICTUS MD STRATEGIES CORP. (“Invictus” or the “Company”) (TSXV:GENE) (OTC:IVITF) (FRA: 8IS1) is pleased to announce the addition of former Heineken executive Kevin Smith as Vice President Recreational Sales, commencing October 1, 2018, and Sarah Hardy, MBA, as Vice President Medical Sales, effective August 20, 2018.
As former Director of Sales at Heineken Canada, Kevin developed the commercial strategy for Heineken in Western Canada, led the execution of the sales organization’s annual plan, developed relations with key customers in both private and government channels and managed the distributor relationship with Molson Coors. In his role as Vice President Recreational Sales, Kevin will be responsible for building out a team of professionals to maintain strong working relationships with liquor boards and establish a presence in retail stores across the country. With agreements already secured in British Columbia, Alberta, and Saskatchewan, Kevin will oversee Invictus’ initial launch in Western Canada and future development, including working in partnership with GTEC Holdings Ltd. (“GTEC”) (TSXV: GTEC) to unveil multiple retail stores in the coming weeks and months.
FULL RELEASE: https://mjobserver.com/investments/invictus-hires-ex-heineken-executive-kevin-smith-as-vp-recreational-sales-sarah-hardy-as-vp-medical-sales/
Canopy Growth Production Footprint Increases with Further Tweed Farms Licence Expansion
SOURCE: https://mjobserver.com/investments/canopy-growth-production-footprint-increases-with-further-tweed-farms-licence-expansion/
Niagra-on-the-lake, ON — September 17, 2018 — /D.M.O. Newswire/ — Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NYSE:CGC) is pleased to announce that its Tweed Farms Inc. (“Tweed Farms”) site has received licence amendments approving all remaining greenhouse space, bringing the Company’s total licensed footprint to approximately 3.2 million sq. ft. The Company’s Canadian platform is now 57% licensed with the balance under aggressive development towards the previously announced 5.6 million sq. ft. target production footprint. This target excludes significant production capacity projects underway at Canopy Rivers‘ partners and supply available to Canopy Growth through third-party agreements.
“We are a house of cannabis brands and that means we need production infrastructure that can grow a wide range of genetics at scale simultaneously,” said Mark Zekulin, co-CEO and President, Canopy Growth. “I’m proud of this most recent licence and credit our team as we continue our track record of expansion and execution.”
REST OF RELEASE: https://mjobserver.com/investments/canopy-growth-production-footprint-increases-with-further-tweed-farms-licence-expansion/
AXIM Biotechnologies Signs LOI for Distribution of Products Throughout Australia and New Zealand
SOURCE: https://mjobserver.com/investments/axim-biotechnologies-signs-loi-for-distribution-of-products-throughout-australia-and-new-zealand/
New York, NY — September 13, 2018 — /D.M.O. Newswire/ — AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has signed a Letter of Intent (“LOI”) with Impression Healthcare Limited (“Impression”), Australia’s largest home dental impression company, for exclusive distribution of all AXIM® Biotech products throughout Australia and New Zealand.
Per the LOI, both parties will endeavor to co-develop new products, initially for pre-clinical and phase 1 trials (among other clinical trials), including an oral rinse liquid targeted for the treatment of oral mucositis, strep throat, oral infections and gum disease. Pending initial discussions and an internal review of AXIM® Biotech and its product offerings, Impression will collaborate with the company for the licensing and distribution of its current and future cannabinoid-based therapeutic products for distribution in Australia and New Zealand.
FULL RELEASE: https://mjobserver.com/investments/axim-biotechnologies-signs-loi-for-distribution-of-products-throughout-australia-and-new-zealand/
Veritas Enters Into LOI for Sale of Sechelt Organic Marijuana
SOURCE: https://mjobserver.com/investments/veritas-enters-into-loi-for-sale-of-sechelt-organic-marijuana/
Vancouver, British Columbia — September 13, 2018 — /D.M.O. Newswire/ — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that the Company has entered into a Non-Binding Letter of Intent (“LOI”) to sell all of the issued and outstanding common shares of Sechelt Organic Marijuana Inc. (“Sechelt”) to Leis Industries Limited (“Leis”).
Under the terms of the LOI, Leis will pay $350,000 CDN in cash or $350,000 CDN in common shares at a deemed price of the lessor of market price and $0.40 per share to acquire 100% of the outstanding shares of Sechelt. Both parties have agreed to conduct due diligence prior to the execution of a definitive agreement which must be executed by no later than October 31, 2018.
REST OF RELEASE: https://mjobserver.com/investments/veritas-enters-into-loi-for-sale-of-sechelt-organic-marijuana/
LiveWell Canada Completes Initial Phase of Artiva Facility for Licensing
SOURCE: https://mjobserver.com/investments/livewell-canada-completes-initial-phase-of-artiva-facility-for-licensing/
Ottawa, ON — September 13, 2018 — /D.M.O. Newswire/ — LiveWell Canada Inc. (“LiveWell” or the “Company”), (TSXV:LVWL), is pleased to announce the completion of the initial phase of the Artiva facility in Ottawa for licensing. In cooperation with its partners Canopy Growth and Canopy Rivers, the Company has prepared its Confirmation of Readiness (“COR”) package for submission to Health Canada to demonstrate its compliance with the Access to Cannabis for Medical Purposes Regulation (ACMPR) security requirements, for the purposes of obtaining a production license.
Upon receipt of its production license, the Company plans to immediately begin the next phase of expansion at the site. Subject to Health Canada and other standard regulatory approvals, the Company anticipates being ready to begin production once the production license has been granted.
The Artiva facility is strategically located in the nations capital in Ottawa, Ontario. The property sits on 100 acres of land with 540,000 square feet of existing greenhouses and 200,000 square feet of hot houses.
FULL RELEASE: https://mjobserver.com/investments/livewell-canada-completes-initial-phase-of-artiva-facility-for-licensing/
Liberty Health Enters Exclusive Partnership to Develop AI-Driven Analytics for Increased Crop Output
SOURCE: https://mjobserver.com/investments/stocks/liberty-health-lhs-lhsif-enters-exclusive-partnership-to-develop-ai-driven-analytics-for-increased-crop-output/
Gainesville, FL — September 13, 2018 — /D.M.O. Newswire/ — Liberty Health Sciences Inc. (CSE:LHS) (OTC:LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of trusted, high quality cannabis experiences, announced today that they have entered an exclusive partnership with AdaViv Inc., a hardware-enabled, predictive agriculture company, to improve production of cannabis at its Liberty Health Sciences 360 Innovation Campus in Gainesville, FL.
AdaViv will integrate its adaptive Computer Vision software and Machine Learning platform into Liberty’s 360 Innovation Campus and, together, will look to push the state-of-the-art in greenhouse technology and precision growing to new levels of productivity and efficiency.
AdaViv’s technology enables 24/7 plant-level inspection as well as AI computer vision to uncover hidden plant biometrics that translates data into actionable insights for growers like Liberty. Founded by an interdisciplinary team of MIT researchers and alumni, AdaViv is led by Dr. Ian Seiferling (CEO), Julian Ortiz (COO, MBA MIT Sloan ’19) and Dr. Thomas Matarazzo (CTO). AdaViv emerged from MIT Delta V, the capstone entrepreneurship accelerator at MIT, and the MIT DesignX accelerator. In 2018, AdaViv was selected as one of the first grantees of Microsoft AI for Earth.
FULL RELEASE: https://mjobserver.com/investments/stocks/liberty-health-lhs-lhsif-enters-exclusive-partnership-to-develop-ai-driven-analytics-for-increased-crop-output/
Crop Developing Cannadrink CBD-Infused Beverages
SOURCE: https://mjobserver.com/investments/stocks/crop-developing-cannadrink-cbd-infused-beverages/
Vancouver, B.C. — September 13, 2018 — /D.M.O. Newswire/ — CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF) announced today it is developing a new cannabis-infused line of soft drinks. Called ‘CANNADRINK’, the beverage will be developed to be a zero calorie, non-GMO, ketogenic-friendly line of soda pop, and will include tea and coffee versions.
The global carbonated soft drinks market is projected to reach USD 605.6 Billion by 2025, according to a March 2018 report by Grand View Research, Inc.
CROP Infrastructure Director and CEO, Michael Yorke, stated: “The cannabis-infused beverages market has attracted the attention of world class beverage companies as legalization spreads. We see it as a tremendous opportunity for CROP Infrastructure’s branding & IP portfolio and as an axillary opportunity for each of our cultivation tenants Globally.
REST OF RELEASE: https://mjobserver.com/investments/stocks/crop-developing-cannadrink-cbd-infused-beverages/
Organigram Invests in Hyasynth Biologicals Inc.
SOURCE: https://mjobserver.com/investments/stocks/organigram-ogi-ogrmf-invests-in-hyasynth-biologicals-inc/
Moncton, NB — September 13, 2018 — /D.M.O. Newswire/ — Organigram Holdings Inc. (TSXV:OGI) (OTC:OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of medical marijuana, is pleased to announce the closing of its strategic investment in convertible secured debentures (the “Debentures”), to be purchased in three tranches and valued in the aggregate at $10 million, of Hyasynth Biologicals Inc. (“Hyasynth”), a biotechnology company based in Montreal and leader in the field of cannabinoid science and biosynthesis.
Hyasynth’s patent-pending enzymes, yeast cells and processes make it possible to produce phytocannabinoids and phytocannabinoid analogues in genetically modified strains of yeast. Hyasynth’s proprietary enzymes and yeast strains have to date allowed them to make CBG, CBD and other cannabinoids for novel and specialized products, including vapourizable cannabis products and cannabis-infused beverages, as well as pharmaceutical ingredients, for a fraction of the cost of traditional plant-based production. The company will continue to develop a comprehensive platform of cannabinoids beyond THC, CBD and CBG for both medical and recreational use.
FULL RELEASE: https://mjobserver.com/investments/stocks/organigram-ogi-ogrmf-invests-in-hyasynth-biologicals-inc/
Inner Spirit Holdings Makes Strategic Investment in High Times Holdings Corp.
SOURCE: https://mjobserver.com/investments/stocks/inner-spirit-holdings-makes-strategic-investment-in-high-times-holdings-corp/
Calgary, AB — September 13, 2018 — /D.M.O. Newswire/ — Inner Spirit Holdings Ltd. (“Inner Spirit” or “the Company”) (CSE:ISH), a specialty retailer and franchisor establishing recreational cannabis dispensaries across Canada under the Spiritleaf brand, today announced that it has made a strategic investment in High Times Holdings Corp. (“High Times”), acquiring 10,000 shares of High Times for $110,000 USD. The investment is part of High Times’ crowdfunding campaign in anticipation of its planned NASDAQ listing later this year. In connection with the investment, Inner Spirit has been granted the right to, among other things, distribute High Times magazine in Spiritleaf stores across Canada.
In addition, as part of the transaction with High Times, Inner Spirit and Spiritleaf customers, as well as other stakeholders, will have the opportunity to share in lifetime Super VIP access to all future and expanding High Times’ Cannabis Cup festivals around the world. The Limited-Edition Cannabis Cup Investor Trophy and other collectable items, including a copy of the legendary inaugural High Times issue, will be displayed at the Inner Spirit head office and Spiritleaf stores across Canada.
FULL RELEASE: https://mjobserver.com/investments/stocks/inner-spirit-holdings-makes-strategic-investment-in-high-times-holdings-corp/
FSD Pharma to Expand into Jamaican Market and Introduce FSD Jamaica
SOURCE: https://mjobserver.com/investments/fsd-pharma-to-expand-into-jamaican-market-and-introduce-fsd-jamaica/
Toronto, ON — September 13, 2018 — /D.M.O. Newswire/ — FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) (OTC:FSDDF) (FRA: 0K9) is pleased to announce that it intends to launch a strategic partnership into the Jamaican cannabis market as part of its plan to expand internationally. FSD has signed a Letter of Intent (“LOI”) effective September 10, 2018 with JJAMACANN Inc. (“JJAMACANN”) to form a joint venture operating as FSD Jamaica (“FSD Jamaica”). FSD Jamaica expects to partner locally with Nature’s Purest Limited (“NPL”), a Jamaican corporation with a cultivation license and existing operations in Jamaica.
“We are excited to be working with a world-class and knowledgeable team of local experts and entrepreneurs with extensive cannabis cultivation experience. Jamaica has historically produced some of the best cannabis over the past 50 years. FSD Jamaica intends to take advantage of the ideal climate and soil conditions on the NPL property and surrounding area to produce the highest quality cannabis, hemp and cannabinoid products possible. FSD Jamaica is well-positioned to bring Jamaican branded, world class medical and recreational products to market by 2019,” said Anthony Durkacz, Director of FSD.
FULL RELEASE: https://mjobserver.com/investments/fsd-pharma-to-expand-into-jamaican-market-and-introduce-fsd-jamaica/
Namaste Signs Binding Terms Sheet to Acquire UK Pharmaceutical Distribution Company
SOURCE: https://mjobserver.com/investments/stocks/namaste-n-nxttf-signs-binding-terms-sheet-to-acquire-uk-pharmaceutical-distribution-company/
Vancouver, B.C. — September 13, 2018 — /D.M.O. Newswire/ — Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRA:M5BQ) (OTC:NXTTF) is pleased to announce that the Company’s wholly-owned subsidiary, Namaste Bahamas Inc. (“Namaste Bahamas”), has signed a Binding Terms Sheet (“Terms Sheet”) to acquire all of the issued and outstanding shares of UK-Based AF Trading Ltd. (operating as “Access Fulfillment” or “accessfulfilment.com”). Access Fulfillment operates a 30,000 square-foot distribution facility in the UK and holds a Wholesale Distribution Authorization (Human) License issued by the Medicines and Healthcare Products Regulatory Agency (“MHRA”) which allows Access Fulfillment to distribute pharmaceutical products throughout the UK. The acquisition of Access Fulfillment is the first step in Namaste developing its future medical cannabis distribution platform in the UK, which represents a much larger customer base than that of its Canadian operations. The Company intends to launch a platform similar to its Canadian wholly-owned subsidiary Cannmart Inc. (“Cannmart”) within the UK market to help monetize on its database of over 500,000 customers.
REST OF RELEASE: https://mjobserver.com/investments/stocks/namaste-n-nxttf-signs-binding-terms-sheet-to-acquire-uk-pharmaceutical-distribution-company/
CannaRoyalty Provides Strategic Financing to Brand Partner Utopia Cannabis to Drive Revenue Growth
SOURCE: https://mjobserver.com/investments/cannaroyalty-provides-strategic-financing-to-brand-partner-utopia-cannabis-to-drive-revenue-growth/
Ottawa, ON — September 13, 2018 — /D.M.O. Newswire/ — CannaRoyalty Corp. (CSE:CRZ) (OTC:CNNRF) (“CannaRoyalty”) and its subsidiary RVR Distribution (“RVR”) (together the “Companies”) today announced that the Companies have agreed to provide strategic financing to support the expansion and growth of Utopia Cannabis (“Utopia”), an award-winning California-based cannabis brand focused on curating clean, best-in-class cannabis flowers, extracts and edibles. Under the Agreement, CannaRoyalty will advance USD$750,000 to finance a forward purchase of manufactured products, including Utopia-branded jarred extracts, vaporizer cartridges and edibles (the “Inventory”).
The advanced funds will be used as working capital to accelerate Utopia’s manufacturing and production schedule at their newly permitted Type-7 Manufacturing facility.
Afzal Hasan, President and General Counsel at CannaRoyalty said, “At the end of 2017, we highlighted our mission to become the home of origin for the global cannabis brands of the future, leveraging our access to distribution, manufacturing infrastructure and resources to help promising cannabis brands scale up. Through the course of this year, we’ve been busy building that home of origin for tomorrow’s global brands, specifically for authentic entrepreneurs like Utopia to share with us. This financing represents the first of many in which we will provide these partners with the tools and resources that they need to lead the industry, first locally in California and then eventually on a global scale. And importantly, we are doing this on non-dilutive terms that allow our brand partners to reap the benefits of their hard-work. We are confident that our unique approach makes us strategic partner of choice for the global cannabis brands of tomorrow.”
REST OF RELEASE: https://mjobserver.com/investments/cannaroyalty-provides-strategic-financing-to-brand-partner-utopia-cannabis-to-drive-revenue-growth/
Cronos Group Inc. Launches New Recreational Brand Spinach
SOURCE: https://mjobserver.com/investments/stocks/cronos-group-inc-launches-new-recreational-brand-spinach/
Toronto, ON — September 13, 2018 — /D.M.O. Newswire/ — Today, Cronos Group Inc. (“Cronos Group” or the “Company”) (NASDAQ:CRON) (TSX:CRON) is pleased to announce the launch of its second cannabis brand for the domestic recreational market, Spinach™.
On October 17, 2018, Canada is expected to become the first G7 country to federally legalize recreational cannabis. This watershed moment means that consumers in Canada will be able to purchase high quality Spinach™ without fear of persecution for their love of beautiful green plants.
REST OF RELEASE: https://mjobserver.com/investments/stocks/cronos-group-inc-launches-new-recreational-brand-spinach/
Looks Like Helix is Making Moves in Canada
Check out the release from this AM:
https://mjobserver.com/investments/helix-tcs-inc-to-bolster-canadian-presence-in-anticipation-of-recreational-legalization-in-october/
The Green Organic Dutchman Launches its Premier Certified Organic Cannabis Brand
SOURCE: https://mjobserver.com/investments/the-green-organic-dutchman-launches-its-premier-certified-organic-cannabis-brand/
Toronto, ON — September 12, 2018 — /D.M.O. Newswire/ — The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (OTC:TGODF) is pleased to announce the launch of its premium, certified organic cannabis brand. This preeminent launch coincides with Canadian Organic Week, the largest annual celebration of organic food, farming and products across the country. This is a pivotal step for the Company in becoming the largest, organic cannabis brand in the world.
TGOD cannabis adheres to the highest production standards for organic cultivation – the product is grown naturally in Canadian soil, without the use of synthetic pesticides, herbicides or fertilizers. According to a 2018 Hill & Knowlton research study, 57% of Canadian medical cannabis consumers and 43% of recreational cannabis consumers prefer organic cannabis. Of 116 licensed producers in Canada, TGOD is one of only two that are certified organic.
REST OF RELEASE: https://mjobserver.com/investments/the-green-organic-dutchman-launches-its-premier-certified-organic-cannabis-brand/
Marapharm Ventures Inc. Updates Shareholders on its North Las Vegas, Nevada facilities
SOURCE: https://mjobserver.com/investments/marapharm-ventures-inc-updates-shareholders-on-its-north-las-vegas-nevada-facilities/
Kelowna, BC — September 12, 2018 — /D.M.O. Newswire/ — Marapharm Ventures Inc. (CSE:MDM) (OTC:MRPHF) (FSE:2M0) (“Marapharm” or the “Company”) provides an update to shareholders on the status of permitting for final occupancy and continued cultivation in the temporary buildings.
Our contractor, Rafael Construction and Engineer, Pacific Design Concepts are “quarterbacking” their efforts to complete requirements as quickly as possible. Working with the City of North Las Vegas, Fire Department, and general contractors to conclude the final permitting necessary for our Certificates of Occupancy. Many of the city departments including Planning, Building Inspection and Fire have been extremely short staffed which have contributed to delays.
Kurt Keating, Director of Operations, reports: The existing vegetative plants are flourishing and vibrant. We are preparing our core genetics for propagation by increasing our plant count to meet our production cycle demands, in preparation for transitioning to the new buildings.
FULL RELEASE: https://mjobserver.com/investments/marapharm-ventures-inc-updates-shareholders-on-its-north-las-vegas-nevada-facilities/
KushCo Holdings Adds to International Expansion with Opening of China Office
SOURCE: https://mjobserver.com/investments/stocks/kushco-holdings-kshb-opens-china-office/
Garden Grove, CA — September 12, 2018 — /D.M.O. Newswire/ — KushCo Holdings Inc. (OTC:KSHB) (“KushCo” or the “Company”), the parent company of innovative cannabis industry leaders such as Kush Bottles, Kush Energy, The Hybrid Creative, and Koleto Packaging Solutions, which provide a range of services and products for the regulated cannabis, CBD and other related industries, announced today the second international expansion of KushCo Holdings with an office in the Jiangbei District of Ningbo, China, establishing a physical presence that will further enable the Company to develop stronger manufacturing relationships, maintain consistent high quality standards for customer needs globally and establish the Company as a leading innovator of proprietary child resistant packaging options for the legalized cannabis industry.
The KushCo Holdings office in China includes two key team members who recently relocated to the Company’s China office from the United States, including Diana Malone, Director Global Sourcing and Quality Control, with experience working internationally and improving manufacturer relationships. Additionally, KushCo Holdings has four local office members who manage quality control inspections, as well as new product development processes. This ensures that as proprietary products are innovated and molded, they can seamlessly be produced and absorbed into the Kush Bottles distribution platform.
REST OF RELEASE: https://mjobserver.com/investments/stocks/kushco-holdings-kshb-opens-china-office/
Namaste Signs UK and EU CBD Supply Agreement with BlueSky Biologicals Inc.
SOURCE: https://mjobserver.com/investments/stocks/namaste-signs-uk-and-eu-cbd-supply-agreement-with-bluesky-biologicals-inc/
Vancouver, B.C. — September 12, 2018 — /D.M.O. Newswire/ — Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRA:M5BQ) (OTC:NXTTF) is pleased to announce that the Company’s wholly-owned subsidiary, Namaste Bahamas Inc. (“Namaste Bahamas”), has signed a distribution agreement (the “Distribution Agreement”) with BlueSky Biologicals Inc. (“BlueSky”); a private British Columbia company; whereby Namaste Bahamas will distribute BlueSky’sfull-spectrum, hemp-derived cannabidiol (“CBD”) products in its UK and European marketplace. The UK has classified CBD as a food supplement, as such, Namaste has been focused on building a carefully curated CBD supply chain for its UK platform. Namaste’s launch of CBD sales in the UK and EU are the first steps of the Company’s initiative to leverage its platform, technology and consumer databases to enter into cannabis consumable sales in the UK and EU.
In Canada, CBD is regulated under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) program, which restricts non-ACMPR vendors from selling it. CBD is a type of cannabinoid which is present in both cannabis and industrial hemp. Most CBD products outside of Canada are produced using industrial hemp, which is naturally high in CBD and low in delta-9 tetrahydrocannabinol (“THC”).
FULL RELEASE: https://mjobserver.com/investments/stocks/namaste-signs-uk-and-eu-cbd-supply-agreement-with-bluesky-biologicals-inc/
Eve & Co Announces Appointment of New CFO
SOURCE: https://mjobserver.com/investments/press-release/eve-co-announces-appointment-of-new-cfo/
Toronto, ON — September 12, 2018 — /D.M.O. Newswire/ — Eve & Co Incorporated (the “Company” or “EVE”) (TSXV:EVE) is pleased to announce that it has appointed Landon Roedding as Chief Financial Officer, effective October 23, 2018.
Mr. Roedding brings over 15 years of experience in accounting, financing, and business development within the public markets and has a demonstrated ability to manage financial and operational challenges while managing a dynamic and growing business. Previously, Mr. Roedding was Controller at Blue Goose Capital Corp., where he led the financial planning, reporting, restructuring and human resource functions. Prior to his role at Blue Goose Capital, Mr. Roedding was Director, Financial Reporting at Kinross Gold, focusing on financial and management reporting as well as internal controls, and Senior Manager of Financial Reporting at Sherritt International Inc., where he led the financial reporting function, upgraded reporting systems and supported M&A activities. Mr Roedding also spent 8 years at PricewaterhouseCoopers LLP, gaining significant experience in public company reporting, technical IFRS accounting and supporting M&A activity. Mr. Roedding is a Canadian Chartered Professional Accountant and holds an Honours Economics and Accounting degree from Wilfrid Laurier University. Mr. Roedding also serves on the Board of Directors of Project C.A.N.O.E., a not-for-profit charity focused on serving youth facing systemic or mental health barriers.
“I am delighted to join the team at EVE at a very exciting time in their development,” commented Landon Roedding.
FULL RELEASE: https://mjobserver.com/investments/press-release/eve-co-announces-appointment-of-new-cfo/
Did you all see the tweet today?
Peep this tweet from Citron Research https://mjobserver.com/investments/stocks/trading/citron-research-tweets-ominous-photo-of-a-popping-bubble-to-warn-tilray-investors/
what do you think?
Stem Holdings and Partners Awarded 13 Medical Marijuana Licenses in Oklahoma
SOURCE: https://mjobserver.com/united-states/oklahoma/stem-holdings-inc-and-oklahoma-partners-awarded-13-medical-marijuana-licenses-in-oklahoma/
Boca Raton, FL — September 12, 2018 — /D.M.O. Newswire/ — Stem Holdings Inc. (OTC:STMH) (CSE:STEM), (the “Company” or “Stem”) a publicly traded real estate company specializing in acquiring and improving properties for the cannabis industry, along with its in-state partners have been awarded 4 cultivation, 5 processing, and 4 dispensary licenses by the Oklahoma Medical Marijuana Authority (OMMA).
“Stem’s strategic expansion into Oklahoma furthers our mission in bringing high-quality, compliant and triple tested products to Oklahoma and access to medical marijuana in a safe, comfortable and welcoming environment,” says Stem’s CEO, Adam Berk. “Stem’s real estate expertise and our marijuana partners’ extensive knowledge in medical marijuana cultivation, retail and processing will ensure that we are able to consistently provide patients with the best medical marijuana experience.”
REST OF RELEASE: https://mjobserver.com/united-states/oklahoma/stem-holdings-inc-and-oklahoma-partners-awarded-13-medical-marijuana-licenses-in-oklahoma/
EnWave Announces Shipment of a Pharmaceutical Radiant Energy Vacuum Freeze-Dryer for Merck
SOURCE: https://mjobserver.com/investments/enwave-announces-shipment-of-a-pharmaceutical-radiant-energy-vacuum-freeze-dryer-for-merck/
Vancouver, B.C. — September 12, 2018 — /D.M.O. Newswire/ — EnWave Corporation (TSXV:ENW) (FSE:E4U) (“EnWave”, or the “Company”) announced today that it has successfully completed Factory Acceptance Testing and has shipped its first 9 kW cGMP Radiant Energy Vacuum (“REV™”) pharmaceutical freeze-dryer designed for Merck, known as MSD outside the United States and Canada. The pharmaceutical REV™ machine is designed to meet cGMP standards and to rapidly freeze-dry vials containing pharmaceutical products.
Successful completion of Factory Acceptance Testing demonstrates that REV™ freeze-drying technology met certain throughput and capacity specifications, designated by Merck.
The successful completion of the Factory Acceptance Testing with Merck marks a significant milestone in the scaled-up commercialization of EnWave’s proprietary REVTM technology in the pharmaceutical sector. Following installation, the equipment will undergo site acceptance testing prior to potential processing of pharmaceutical products using the technology.
REST OF RELEASE: https://mjobserver.com/investments/enwave-announces-shipment-of-a-pharmaceutical-radiant-energy-vacuum-freeze-dryer-for-merck/
Supreme Cannabis Signs Cannabis Supply Agreement with Tilray
SOURCE: https://mjobserver.com/investments/supreme-cannabis-signs-cannabis-supply-agreement-with-tilray/
Toronto, ON — September 10, 2018 — /D.M.O. Newswire/ — The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSXV:FIRE) (OTC:SPRWF) (FRA:53S1), announced that the Company’s wholly owned subsidiary, 7ACRES, has entered into a supply agreement to provide dried cannabis to Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, cultivation, processing and distribution currently serving tens of thousands of patients in 11 countries spanning 5 continents.
The value of this initial supply agreement is estimated to be in excess of C$2 million. Dried cannabis provided to Tilray by 7ACRES will be used primarily to support medical cannabis patients in Canada, including Tilray’s robust patient population.
REST OF RELEASE: https://mjobserver.com/investments/supreme-cannabis-signs-cannabis-supply-agreement-with-tilray/
HEXO Acquires Interest in 2M sq. ft. Facility in Belleville, Ontario
SOURCE: https://mjobserver.com/investments/hexo-acquires-interest-in-2m-sq-ft-facility-in-belleville-ontario-to-create-rd-and-manufacturing-centre-of-excellence/
Gatineau, Quebec — September 10, 2018 — /D.M.O. Newswire/ — HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO) has announced the acquisition of an interest in a 2,004,000 sq. ft. facility in Belleville, Ontario. This is the first facility of the Company to be established outside of Quebec, further delivering on its national expansion strategy and providing capacity for the manufacturing of advanced cannabis products, including cosmetics, vapes, non-alcoholic beverages and other edibles.
The centralized location, conveniently located along primary shipping routes in Ontario, presents the opportunity to process and distribute products and to fulfil commitments across Canada. The space also supports the Company’s hub and spoke model. Its scalability, flexibility and location are ideal to deliver on anticipated future joint ventures with Fortune 500 companies for cosmetics, edibles, vapes, and more, positioning it to become a centre of excellence for all of HEXO’s joint ventures. HEXO’s expansion will also lead to the creation of jobs and a rejuvenated employment sector for the area.
Rest of Release: https://mjobserver.com/investments/hexo-acquires-interest-in-2m-sq-ft-facility-in-belleville-ontario-to-create-rd-and-manufacturing-centre-of-excellence/
Aphria made it to top 5 LP gainers today
https://mjobserver.com/investments/stocks/5-of-todays-best-performing-canadian-l-p-stocks-2/
Tilray Shares Continue Ascent, Making it Best Performer Out of Last 100 IPOs in the U.S.
SOURCE: https://mjobserver.com/investments/stocks/tilray-tlry-shares-continue-ascent-making-it-the-best-performer-out-of-the-last-100-u-s-ipos/
Following the recent release of Q2 2018 earnings from Tilray, Inc. (NASDAQ:TLRY), shares of the international cannabis conglomerate have risen further, continuing their rapid ascent towards sky-high price-to-sales multiples.
Given a rise in TLRY share price of over 20% between the close on August 28th and the close today on August 29th, the pot stock has officially secured the position as one of the best performing IPOs in a while.....
REST OF ARTICLE: https://mjobserver.com/investments/stocks/tilray-tlry-shares-continue-ascent-making-it-the-best-performer-out-of-the-last-100-u-s-ipos/
United Cannabis Begins Clinical Trials On Prana P1 THC Activated Capsules
FULL RELEASE: https://www.dailymarijuanaobserver.com/single-post/2018/08/01/CNAB-United-Cannabis-Begins-Clinical-Trials-On-Prana-P1-THC-Activated-Capsules
DENVER, CO -- /D.M.O. Newswire/ -- August 1, 2018 / United Cannabis Corporation (OTC:CNAB) (the "Company" or "United Cannabis") today announced that it has initiated clinical trials on its Prana Bio Nutrient Medicinals P1 Capsules for the treatment of chronic pain at Jamaica's University of the West Indies.
The study, titled, "An Open Label, Phase 1, 2-Way crossover study evaluating the pharmacokinetics of Prana P1 THC activated capsules," is be conducted in conjunction with Cannabinoid Research & Development ("CRD"), the Company's Jamaican subsidiary, at the Centre For Cannabis Research at the University's Mona Campus.
Earnest Blackmon, Chief Executive Officer of United Cannabis, commented on the announcement, "We are very proud to announce the commencement of our clinical trials; we have been working toward this goal since we started the Company. The Prana products represent the culmination of years of research and development, and I am confident that the results will confirm the anecdotal evidence we have seen with patients since first introducing our Prana product line six years ago."
Canopy Growth to Announce First Quarter Fiscal 2019 Financial Results
FULL RELEASE: https://www.dailymarijuanaobserver.com/single-post/2018/08/01/CGC-Canopy-Growth-to-Announce-First-Quarter-Fiscal-2019-Financial-Results
SMITHS FALLS, ON, Aug. 1, 2018 -- /D.M.O. Newswire/ -- Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) ("Canopy Growth") will release its financial results for the first quarter fiscal 2019 ended June 30, 2018 on August 14, 2018.
Following the release of its first quarter 2019 financial results, Canopy Growth will host a conference call and audio webcast with Bruce Linton, Chairman & Co-CEO and Tim Saunders, EVP & CFO at 8:00 AM Eastern Time the same day.
Webcast Information
A live audio webcast will be available at:
https://event.on24.com/wcc/r/1800764/F7B6A3CFF26AED5C28B555A658CF1105
.....
MPX Secures Approval to Open First Managed Dispensary in Maryland
FULL RELEASE: https://www.dailymarijuanaobserver.com/single-post/2018/07/17/MPX-MPXEF-Secures-Approval-to-Open-First-Managed-Dispensary-in-Maryland
TORONTO, July 17, 2018 -- /D.M.O. Newswire/ -- MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) announced that final licensing approval was secured from the Maryland Medical Cannabis Commission (“MMCC”) on June 26, 2018 to open the first dispensary in the State of Maryland to be managed by S8 Management, LLC (“S8 Management”), An indirect wholly-owned subsidiary of the Corporation. The dispensary, which is owned by Budding Rose Inc., will operate under the Company’s “Health for Life” brand.
The Health For Life dispensary is located at 4909 Fairmont Avenue, Bethesda, Maryland and will welcome its first patients on Saturday, August 4, 2018 offering special deals throughout the day. The dispensary is equipped to service hundreds of patients per day and has a top-of-the-line point of sale system to serve patients efficiently and adhere to state reporting requirements in real time. It is located in a high-traffic area of downtown Bethesda, Maryland, in close proximity to the Walter Reed Military Medical Center and National Institutes of Health. Bethesda, Maryland is located within the Capital Beltway and is one of the wealthiest and most health conscious communities in the Capital Region.
“According to the MMCC, approximately 32,000 patients are currently certified for use of medical cannabis in Maryland and over 46,000 are signed up to become eligible. With the opening of the Health for Life Bethesda dispensary, we are pleased to further strengthen our first-mover advantage in the state. We have received a warm welcome from local business owners and the wider Bethesda community and look forward to serving patients, providing jobs and contributing to the local economy,” stated W. Scott Boyes, MPX’s Chairman, President and CEO.
Therapix Announces Positive Data From Pre-Clinical Studies for its Pain Drug
FULL RELEASE: https://mjobserver.com/investments/trpx-therapix-announces-positive-data-from-pre-clinical-studies-for-its-pain-drug/
Tel Aviv, Israel — July 17, 2018 — /D.M.O. Newswire/ — Therapix Biosciences Ltd. (NASDAQ:TRPX), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced today positive results in its pre-clinical studies evaluating THX-160, a novel pharmaceutical CB2 Receptor agonist for the treatment of pain. This innovative CB2 receptor agonist, which was found to be superior out of two candidates the Company had tested, was synthesized by Raphael Mechoulam, Ph.D., Professor of Medicinal Chemistry at the Hebrew University, and a member of the Therapix Scientific Advisory Board.
To date, prescription opioids are considered to be the most effective treatment for moderate-to-severe pain, but their abuse has been identified by the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) as a significant public health issue.
In the preclinical studies, THX-160 was well tolerated and did not cause any significant adverse clinical effects. In addition, efficacy studies demonstrated the analgesic superiority of THX-160 over control and were comparable to high-dose morphine analgesic effects and in some instances exerted greater potency. The efficacy and safety of THX-160 was shown for both acute and chronic pain.
“This encouraging data, along with prior published preclinical efficacy results for a CB2R agonist’s involvement in pain relief, reinforce our belief that our lead drug candidate, THX-160, has a favorable safety and efficacy profile that could potentially address the unmet need for well-tolerated and safe oral pain therapies with improved patient quality of life,” said Dr. Adi Zuloff-Shani, Chief Technology Officer at Therapix. “The novel cannabinoid we added to the Company’s portfolio highlights Therapix’s commitment to continue and develop our cannabinoid platform, and potentially translating into innovative new treatments.”
TGOD and Epican Medicinals Open Flagship Retail Dispensary in Jamaica
FULL RELEASE: https://mjobserver.com/investments/tgod-and-epican-medicinals-open-flagship-retail-dispensary-in-jamaica/
Kingston, Jamaica — July 17, 2018 — /D.M.O. Newswire/ — The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (OTC:TGODF) is pleased to announce, in conjunction with Epican Medicinals (“Epican”), the successful opening of its first legal cannabis retail store in Jamaica, on Saturday, July 14th. This flagship location provides Epican and TGOD with immediate revenue from the sale of premium Jamaican grown organic cannabis and further exemplifies TGOD’s value-added approach to partnerships.
The ~4,000 sq. ft. flagship dispensary in Kingston represents the first of several Epican Herb Houses scheduled to be completed across Jamaica by the end of 2018. These locations will serve the medical needs of Jamaica’s 3 million residents and over 3.5 million visitors each year.
“Immediate revenue has always been an important component of Epican business plan,” said TGOD CEO, Brian Athaide. “We expect Epican to increase revenues significantly in the coming months as production increases and more Herb Houses come online.”
TGOD investments are structured as true partnerships, where portfolio companies receive support and industry leading knowledge. This knowledge transfer includes cultivation methodology, extraction, R&D, and organic certification, through to accounting, auditing, sales, marketing, and distribution....
Scythian Sells Latin American and Caribbean Assets to Aphria in All Stock Deal
FULL RELEASE: https://mjobserver.com/investments/scythian-announces-strategic-sale-of-latin-american-and-caribbean-assets-in-193000000-deal-to-aphria/
Toronto, ON — July 17, 2018 — /D.M.O. Newswire/ — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (FRA:9SB) (OTC:SCCYF) is pleased to announce that it has entered into a strategic deal with Aphria Inc. (TSX:APH) (OTC:APHQF) (“Aphria”), a leading global cannabis company, for Aphria to acquire Scythian’s Latin American and Caribbean assets. It is expected that the Company’s strategic relationship with Aphria will provide leverage for early stage investments in emerging international markets.
Pursuant to a definitive share purchase agreement (the “Agreement”), Aphria will acquire 100% of the issued and outstanding common shares of LATAM Holdings Inc., a direct, wholly-owned subsidiary of Scythian, which following the closing of previously announced transactions will own licenses and other assets held through subsidiaries in Argentina, Colombia and Jamaica (the “Transaction”).
As a result of the Transaction, Aphria will indirectly acquire the following interests:
100% of Marigold Acquisitions Inc., an entity which owns 100% of Hampstead Holdings Ltd., a Bermuda incorporated entity, which owns 49% of Marigold Projects Jamaica Limited, which has received licenses to cultivate and conditional licenses to process, sell and provide therapeutic or spa services using cannabis products in Jamaica;
100% of ABP, S.A., an Argentinean pharmaceutical import and distribution company, currently licensed for the importation of CBD oil; and
90% of Colcanna S.A.S., a Colombian medical cannabis producer, currently licensed for cultivation and importation of CBD, extraction, production, research and exportation of medical cannabis products, (collectively, the “Target Corporations”).
Scythian will also grant Aphria a right to purchase from Scythian, in one or more separate tranches, up to 90% of the issued and outstanding common shares of an entity in Brazil (which Scythian is currently seeking to acquire) at terms to be agreed upon.
Maricann License Approved by Maltese Government
SOURCE: https://mjobserver.com/investments/maricann-license-approved-by-maltese-government/
TORONTO, July 17, 2018 (GLOBE NEWSWIRE) — Maricann Group Inc. (CSE:MARI) (FRANKFURT:75M) (OTCQB:MRRCF) (“Maricann” or the “Company) is pleased to announce that Malta Enterprise (the country’s official economic development agency and the government entity responsible for licenses) has approved Maricann’s application to set up a business in Malta to manufacture finished dose medical cannabis.
CROP Completes Retrofit; Tenant Starts Production at Washington Facility
SOURCE: https://mjobserver.com/investments/crop-completes-retrofit-and-tenant-starts-production-at-washington-state-facility-the-park/
VANCOUVER, British Columbia, July 17, 2018 (GLOBE NEWSWIRE) — CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF) (“CROP” or the “Company”) announced today that it has completed the retrofit and upgrades at its ‘The Park’ state-of-the-art facility in Washington State. Crop’s licensed tenant grower there has now advised that it expects to harvest an initial 350 pounds of high quality cannabis within six weeks and will be at full scale production in September 2018.
Crop’s Nevada CBD Farm Receives Hemp Licence Approval From State
VANCOUVER, British Columbia, July 13, 2018 -- /D.M.O. Newswire/ -- CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF) (“CROP” or the “Company”) announces that its tenant grower “The Hempire Company, LLC” has been issued a formal Nevada hemp licence covering all 240 pivoted acres of CROP’s Nye County, Nevada farm. Planting has been completed on 120 acres and is now underway on an additional 120 acres, consisting of only approved organic and natural materials in agriculture production in order to be deemed an Organic operation.
The Nye County agricultural Hemp farm is located in central Nevada and was selected for its temperate climate which is ideal for greenhouse and outdoor growing. The property totals over 315 acres and includes 300 acres of private water rights, with 240 acres under automatic irrigation pivots that also have automatic fertilizer injection systems installed.
The genetics selected, BaOx and Cherry BaOX have a THC content of <0.3% and a CBD content of >15%. It is estimated that the 240 acre pivots will yield 240,000 pounds of hemp flower. Cost of production is not expected to exceed $700,000 USD. The first harvest is expected in early Q4 this year.
FULL RELEASE: https://www.dailymarijuanaobserver.com/single-post/2018/07/13/CropE28099s-Nevada-CBD-Farm-Receives-Hemp-Licence-Approval-From-State
CannTrust's 3 Rec Supply Agreements To exceed 17,000kg
VAUGHAN, ON, July 13, 2018 -- /D.M.O. Newswire/ -- CannTrust Holdings Inc. ("CannTrust" or the "Company") (TSX:TRST), one of Canada's leading licensed producers of cannabis, explodes into the adult use market with its first three recreational cannabis supply agreements. Far surpassing CannTrust's initial sales projections, combined agreements from British Columbia, Alberta and Manitoba for CannTrust's high-quality, standardized cannabis under three recreational brands – Liiv, SYNR.G and Xscape – are projected to exceed 17,000 kilograms annually. The broad range of products include dried flower, pre-rolled joint, oil and capsules. These will be available for legal purchase in cannabis retailers, as well as online, on October 17, 2018. CannTrust is excited to build on this positive momentum as supply agreements with additional provinces are currently being finalized.
FULL RELEASE: https://www.dailymarijuanaobserver.com/single-post/2018/07/13/TRST-CannTrusts-3-Rec-Supply-Agreements-To-exceed-17000kg
Nutritional High Obtains Equipment Lease Funding Commitment
TORONTO, July 13, 2018 -- /D.M.O. Newswire/ -- Nutritional High International Inc. (the “Company” or “Nutritional High”) (CSE:EAT) (OTC:SPLIF) (FRANKFURT:2NU) is pleased to announce that it has received a US$2,000,000 conditional lease commitment (“Lease Line of Credit”) for the funding of new extraction and lab processing equipment from Veterans Capital Corp. or its assignee (the "Lender"). The terms are as follows:
the Lease Line of Credit will have a 3-year term with fixed monthly lease rental payments based on a monthly lease rate factor of 3.3694% of the capital cost;
funding under the proposed Lease Line of Credit will be in increments of US$500,000 or as per each lease schedule;
the Company has the option to extend the lease term for a minimum of 12 months at renewal;
the Lease Line of Credit provides for a buyout option, whereby the Company has an option to purchase all the equipment under the Lease Line of Credit for fair market value, which shall not exceed of 14% of the capital cost;
the Lease Line of Credit will be secured by various new extraction and lab processing equipment, attachments, parts and warranties.
the Company will issue 1,000,000 warrants at an exercise price of C$0.70 per share, expiring 3 years from the date of closing. 25% of the total warrants shall vest upon execution of the Lease Line of Credit agreement and the remaining 75% will vest on a pro-rata basis as the Lender funds the lease schedules.
the Company will pay the Lender certain other fees based on amount funded under the lease schedule.
FULL RELEASE: https://www.dailymarijuanaobserver.com/single-post/2018/07/13/EAT-SPLIF-Nutritional-High-Obtains-Equipment-Lease-Funding-Commitment
Emerald Health Updates on its Differentiated Strategy and Progress
VICTORIA, British Columbia, July 12, 2018 -- /D.M.O. Newswire/ -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTC:EMHTF) (Emerald) is providing an update on its differentiated strategy to excel in the growing cannabis industry.
“In Emerald’s view, the most compelling opportunities and growth in the cannabis industry will arise in serving the unmet needs of individuals seeking medicinal and wellness benefits. We also have evidence that adults using cannabis for purely recreational benefits desire products with predictable characteristics. Our vision is to enable both medicinal and recreational users to ‘consume with confidence,’” said Chris Wagner, CEO of Emerald.
“Our expectation of being in this business is to develop unique, protected products that are preferred by consumers, command high margins, and achieve attractive profit for the company and its shareholders. Our seasoned team, having cumulatively spent hundreds of years in medicine, pharmaceutical development and sales, biotechnology R&D and clinical development, as well as natural health product development, knows how to run the marathon of developing high quality products based on the processes, tools, and quality standards of the life sciences industry. Critically, we also have tremendous consumer sales and marketing expertise, know-how to position and brand products, and are adept at navigating the ins and outs of dealing with large buyers.”
FULL RELEASE: https://www.dailymarijuanaobserver.com/single-post/2018/07/12/EMH-Emerald-Health-Updates-on-its-Differentiated-Strategy-and-Progress